New: Introducing the Finviz Crypto Map

Cytokinetics, Incorporated

Contributing Author

Recent Articles by Cytokinetics, Incorporated

Aug-07	Cytokinetics Reports Second Quarter 2025 Financial Results and Provides Business Update CYTK GlobeNewswire
Jul-24	Cytokinetics to Announce Second Quarter Results On August 7, 2025 CYTK GlobeNewswire
Jul-18	Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) CYTK GlobeNewswire
Jul-10	Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025 CYTK GlobeNewswire
Jun-17	Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CYTK GlobeNewswire
Jun-10	Cytokinetics Announces Call For Proposals For Annual Corporate Giving Program CYTK GlobeNewswire
May-29	Cytokinetics to Participate in the Jefferies Global Healthcare Conference CYTK GlobeNewswire
May-18	Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025 Congress CYTK GlobeNewswire
May-16	Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CYTK GlobeNewswire
May-15	Cytokinetics to Host Symposium on Contemporary Landscapes in Muscle Biology CYTK GlobeNewswire
May-13	Cytokinetics Announces Positive Topline Results From MAPLE-HCM CYTK GlobeNewswire
May-08	Cytokinetics Announces Four Upcoming Presentations at the European Society Of Cardiology Heart Failure 2025 Congress CYTK GlobeNewswire
May-07	Cytokinetics to Hold Annual Meeting of Stockholders CYTK GlobeNewswire
May-06	Cytokinetics Reports First Quarter 2025 Financial Results and Provides Business Update CYTK GlobeNewswire
May-01	Cytokinetics Announces New PDUFA Date for Aficamten in Obstructive Hypertrophic Cardiomyopathy CYTK GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.